Basic Information
| LncRNA/CircRNA Name | DLX6-AS1 |
| Synonyms | NA |
| Region | GRCh38_7:96955141-97014065 |
| Ensemble | ENSG00000231764 |
| Refseq | NR_015448 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, western blot |
| Sample | ESCC tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | By comparing with corresponding tissues, the DLX6-AS1 expression level was significantly higher in CC samples. |
| Pubmed ID | 31539117 |
| Year | 2019 |
| Title | Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS. |
External Links
| Links for DLX6-AS1 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |